Form 4: CONMED Corp: Chief Information Officer Richard Glaze Reports Stock Option Grant
SEC Filing
Richard Glaze, Chief Information Officer of CONMED Corp, reports the acquisition of 11,750 stock options.
Summary
- Richard Glaze, the Chief Information Officer of CONMED Corp, filed a Form 4 on March 5, 2025.
- The filing reports a transaction that occurred on March 3, 2025, where Glaze acquired 11,750 options to purchase common stock at a price of $58.33.
- These options were granted under the company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five-year period.
- Following the reported transaction, Glaze directly owns 11,750 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock option grants to an executive.
Positives
- The grant of stock options aligns the executive's interests with those of the shareholders.
Industry Context
Stock option grants are a common form of executive compensation in the medical technology industry, aligning management's interests with shareholder value.
Stakeholder Impact
- The stock option grant could incentivize the executive to improve company performance, benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the stock option grant. |
| 03/05/2025 | Date of Form 4 filing. |
| 03/03/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.